ReportsnReports
PUNE, MAHARASHTRA, INDIA, Aug. 22, 2022 /EINPresswire.com/ — Global Legionella Testing Market is expected to reach USD 439 Million by 2027, from USD 296 Million in 2022, growing at a CAGR of 8.2% during of the forecast period. The growth of this market is mainly driven by the increase in the geriatric population associated with the increasing prevalence of Legionella-related diseases and the growing demand for rapid diagnostics.
“The PCR segment accounted for the highest growth rate in the legionella testing market, by test type, during the forecast period.”
Legionella testing market is segmented into culture methods, urine antigen testing, direct fluorescent antibody testing, and product-based PCR. In 2021, the PCR segment accounted for the highest growth rate in the Legionella testing market. Market growth can be largely attributed to its speed, versatility, and simplicity.
Download a free sample report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=6132346
“The Water and Other Industries segment accounted for the highest CAGR.”
On the basis of end user, the legionella testing market has been segmented into hospitals, diagnostic laboratories, water industries and others, and other end user. In 2021, the water and other industries segment recorded the highest growth rate. This can be attributed to increasing population and urbanization, as well as increased demand for new water resources
“Asia-Pacific: the region’s fastest growing legionella testing market.”
The global legionella testing market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The Asia-Pacific region is expected to register the highest CAGR during the forecast period. Factors such as government efforts to increase awareness of early diagnosis of diseases and regular health checkups
The main interviews conducted for this report can be categorized as follows:
• By type of business: level 1 – 40%, level 2 – 30% and level 3 – 30%
• By designation: level C – 27%, level D – 18% and others – 55%
• By region: North America -51%, Europe – 21%, Asia-Pacific – 18%, Latin America – 6% and Middle East and Africa – 4%
Lists of companies featured in the report:
• Thermo Fisher Scientific, Inc. (USA)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (USA)
• IDEXX Laboratories, Inc. (USA)
• bioMérieux SA (France)
• Becton, Dickinson and company (USA)
• Alere, Inc. (USA)
• Eurofins Scientific (Luxembourg)
• Roche Diagnostics (Switzerland)
• Pall Corporation (Danaher) (United States)
• Quidel Corporation (USA)
• Eiken Chemical Co., Ltd. (Japan)
• Hologic, Inc. (USA)
• QIAGEN (Germany)
• Takara Bio, Inc. (Japan)
• Environmental Safety Technologies, Inc. (USA)
• Hydrosense (Scotland)
• Accepta Ltd. (UK)
• Lumin Ultra Technologies Ltd. (Canada)
• Pro-Lab Diagnostics, Inc. (Canada)
• BioAlert Solutions (Canada)
• Pacific Water Technology (Australia)
• Aquacert Ltd. (UK)
• DTK Water (UK)
• Sens Solutions (Spain)
• Genomadix, Inc. (USA)
• Phigenics, LLC (United States).
Direct Purchase of Global Legionella Testing Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=6132346
Research Coverage:
This report provides a detailed picture of the Global Legionella Testing Market. It aims to estimate the market size and future growth potential across different segments, such as test type, application, end-user, and region. The report also includes an in-depth competitive analysis of key market players along with their company profiles, recent developments, and key market strategies.
Ganesh Pardeshi
ReportsnReports
+1 888 391 5441
ganesh.pardeshi@reportsandreports.com
